Reducing the burden of chronic obstructive pulmonary disease (part I) : Molecular mechanisms of inflammation in chronic obstructive pulmonary disease;Zmniejszmy ciȩzar przewlekłej obturacyjnej choroby płuc (cz. I) : Mechanizmy molekularne zapalenia w przewlekłej obturacyjnej chorobie płuc

Pneumonologia i Alergologia Polska

Volumn 77, Issue 1, 2009, Pages 66-71

  Semik Orzech, Aleksandra ^a   Pierzchała, Wtadystaw ^a  

^a Katedra i Klinika Pulmonologii la skiego   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INFLAMMATION; METABOLISM; OXIDATIVE STRESS; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM;

ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; NITRIC OXIDE; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 67649236168     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lopez A.D., Shibuya K., Rao C. i wsp. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 2006; 27: 397-412.
2. Feghali-Bostwick CA., Gadgil A.S., Otterbein L.E. i wsp. Autoantibodies in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 2008; 177: 156-163.
3. Barnes P.J., Adcock I.M., Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur. Respir. J. 2005; 25: 552-563.
4. Karrasch S., Holz O., Jorres R.A. Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir. Med. 2008; 102: 1215-1230.
5. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580. (Pubitemid 38901515)
6. Pons A.R., Noguera A., Blanquer D., Sauleda J., Pons J., Agusti A.G. Phenotypic characterization of alveolar macrophages and peripheral blood monocytes in COPD. Eur. Respir. J. 2005; 25: 647-652.
7. O'Donnel R.A., Peebles C., Ward J.A. i wsp. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 2004; 59: 837-842.
8. Chung K.F., Adcock I.M. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur. Respir. J. 2008; 31: 1334-1356.
9. Chrysofakis G., Tzanakis N., Kyriakoy D. i wsp. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004; 125: 71-76.
10. Chung K.F. Inflammatory mediators in chronic obstructive pulmonary disease. Curr. Drug. Targets Inflamm. Allergy 2005; 4: 619-625.
11. Mossman B.T., Lounsbury K.M., Reddy S.P. Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am. J. Respir. Cell Mol. Biol. 2006; 34: 666-669.
12. Szulakowski P., Crowther A.J., Jimenez L.A. i wsp. The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006; 174: 41-50.
13. Ito K., Ito M., Elliott W.M. i wsp. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. 2005; 352: 1967-1976.
14. Rajendrasozhan S., Yang S.R., Kinnula V.L., Rahman I. SIRT1, an anti-inflammatory and anti-aging protein, is decreased in lungs of patients with COPD. Am. J. Respir. Crit. Care Med. 2008 [Epub ahead of print PMID: 18174544].
15. Ito K., Yamamura S., Essilfie-Quaye S. i wsp. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J. Exp. Med. 2006; 203: 7-13.
16. Muller K.C., Welker L., Basile G. i wsp. Lung fibroblasts from patients with emphysema show markers of senescence in vitro. Respir. Res. 2006; 7: 32.
17. Tsuji T., Aoshiba K., Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am. J. Respir. Crit. Care Med. 2006; 174: 886-893.